Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures.
Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged during vascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 23, 2017 | Series C | $14.50M | 5 | Lightstone Ventures | — | Detail |
Jan 1, 2017 | Series C | — | 1 | — | — | Detail |
Aug 18, 2014 | Series B | $18M | 3 | Sante Ventures | — | Detail |
Jul 10, 2012 | Debt Financing | $3.62M | — | — | — | Detail |
Oct 31, 2011 | Series A | $3.37M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lightstone Ventures | Yes | Series C |
Easton Capital | — | Series C |
HealthCor Partners | — | Series C |
Incept LLC | — | Series C |
Sante Ventures | — | Series C |
Gore Range Capital | — | Series C |